Opsismodysplasia is a rare, autosomal-recessive skeletal dysplasia characterized by short stature, characteristic facial features, and in some cases severe renal phosphate wasting. We used linkage analysis and whole-genome sequencing of a consanguineous trio to discover that mutations in inositol polyphosphate phosphatase-like 1 (INPPL1) cause opsismodysplasia with or without renal phosphate wasting. Evaluation of 12 families with opsismodysplasia revealed that INPPL1 mutations explain~60% of cases overall, including both of the families in our cohort with more than one affected child and 50% of the simplex cases.
Opsismodysplasia (MIM 258480) is a rare skeletal dysplasia with delayed bone maturation (from ''opsismos,'' Greek for ''late''). [1] [2] [3] The clinical signs observed at birth include short limbs, small hands and feet, relative macrocephaly with a large anterior fontanel, and characteristic craniofacial abnormalities including a prominent brow, depressed nasal bridge, a small anteverted nose, and a relatively long philtrum. Death secondary to respiratory failure during the first few years of life was reported in the cases originally described but the outcome is now known to be highly variable with multiple long-term survivors. 3 Typical radiographic findings include shortened long bones with very delayed epiphyseal ossification, severe platyspondyly, metaphyseal cupping, and characteristic abnormalities of the metacarpals and phalanges. Recurrence within sibships and incidence in consanguineous pedigrees suggest that the mode of inheritance of opsismodysplasia is autosomal recessive. [1] [2] [3] [4] [5] [6] To determine the genetic basis of opsismodysplasia, one of two siblings with opsismodysplasia and severe hypophosphatemia because of renal phosphate wasting (AII-1 in Table 1 , Figures 1 and 2 , and Figure S1 available online) and his consanguineous parents were genotyped with the HumanCytoSNP-12 DNA Analysis BeadChip, at nearly 300,000 single-nucleotide polymorphisms (SNPs). All studies were approved by the institutional review boards of the University of Washington and Seattle Children's Hospital and informed consent was obtained from participants or their parents. Self-reported Hispanic and Native American ancestry was first confirmed with EIGENSTRAT. Parametric linkage analysis by a fully penetrant rare recessive model (f 2 ¼ 1; q ¼ 0.0001) and allele frequencies estimated from unrelated members of the HapMap CEPH, European, Chinese, Japanese, and Mexican American populations ( Figure S2 ) was performed with ALLEGRO on an approximately 0.2 cM SNP map in an 11 person pedigree that included the consanguineous parents of the proband. Ten genomic regions reached a maximum LOD score of 1.5 ( Figure S3 Next, whole-genome sequencing was performed on both parents and the same affected sibling used in the linkage studies. In brief, 1 mg of genomic DNA was subjected to a series of shotgun library construction steps, including fragmentation through acoustic sonication (Covaris), end-polishing (NEBNext End Repair kit), A-tailing (NEBNext dA Tailing kit), and ligation of 8 bp barcoded sequencing adaptors (Enzymatics Ultrapure T4 Ligase). Libraries were automatically size selected for fragments 350-550 bp in length with the automated PippinPrep cartridge system, which provides for fine control over the insert size and physically isolates each size fraction in separate chambers. Prior to sequencing, the library was amplified via PCR (Kapa HiFi Hotsart). To facilitate optimal Table 1 . Continued
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Soft and/or doughy skin flow-cell loading, the library concentration was determined by triplicate qPCR (Kapa Illumina Library Quantification kit) and molecular weight distributions verified on the Agilent Bioanalyzer. Massively parallel sequencingby-synthesis via fluorescently labeled, reversibly terminating nucleotides was carried out on the HiSeq sequencer. Samples were sequenced to at least 303 average depth with paired-end 100 bp reads; a third read sequenced the 8 bp index to confirm sample assignments. Demultiplexed BAM files were aligned to a human reference (hg19) with the Burrows-Wheeler Aligner. Table 1 , where a detailed description of each individual is provided. Read data from a flow-cell lane were treated independently for alignment and QC purposes in instances where the merging of data from multiple lanes was required. All aligned read data were subjected to (1) removal of duplicate reads, (2) Variant data were annotated with the SeattleSeq Annotation Server.
Regions under linkage peaks covering a total of~157 Mb were examined for rare and/or novel functional variation including missense, nonsense, splice site mutations, and indels. In the proband (AII-1), novel, homozygous missense mutations for which both parents were heterozygous were identified in five genes ( . Sanger sequencing of these variants in the affected sister of the proband (AII-2) revealed that she was homozygous only for variants in INPPL1, NEU3, and CARNS1, thus reducing the number of candidate genes to three. These candidates were further prioritized based on their putative biological function and screened via Sanger sequencing in an unrelated family with a single child with opsismodysplasia. In the first gene screened, INPPL1, the affected child (EII-1 in Table 1 ), who was the product of a consanguineous mating, was found to be homozygous for a nonsense mutation (c.545C>A [p.Ser182*]).
To determine the extent to which INPPL1 mutations explain cases of opsismodysplasia, we used Sanger sequencing to screen ten additional unrelated families (total of ten affected individuals and the unaffected parents of a deceased child from whom a DNA sample was unavailable). These families consisted of nine trios in which an affected child was born to unaffected parents and one additional family with two affected siblings. Collectively, between the two families used for discovery and our validation studies, INPPL1 mutations were found in 7/12 (58%) kindreds tested (Table 1) , including both families with more than one individual affected and 5/10 (50%) of the simplex cases. In each of the five families for which DNA was available from one or both parents, heterozygosity for the INPPL1 mutation was found. No other genes that cause phenotypes similar to opsismodysplasia were tested in the INPPL1 mutationnegative cases.
A total of nine unique mutations were identified including four frameshift, one nonsense, one splicing, and three missense mutations (Table 1; Figure 3) . None of the INPPL1 missense, nonsense, or splice site mutations identified in the subjects were found in >13,000 chromosomes sequenced as part of the NHLBI-ESP. In three families, the affected individual(s) was a compound heterozygote. In four kindreds, including all three consanguineous families and one family that was not known to be consanguineous, the affected individuals were homozygous for an INPPL1 mutation. In the latter family (family B in Figure S1 ), inheritance of the mutation from the mother was confirmed, but the paternal sample was unavailable for testing. It is possible that the father is also a heterozygous carrier of this mutation, but a deletion encompassing the region could not be ruled out. However, this mutation (c.768_769del [p.Glu258Alafs*45]) was also shared in a second unrelated family (family C in Figure S1 ) of European ancestry, indicating that there may be a carrier population with this variant.
Three of the frameshift mutations and the nonsense mutation are predicted to lead to premature termination codons at the 5 0 end of the transcript, suggesting that they lead to loss of INPPL1 function. In particular, homozygosity for the Ser182* mutation found in the index case would eliminate most of the functional domains of the protein, including the catalytic domain ( Figure 3 ). Thus, even if transcripts containing this mutation were stable to nonsense-mediated decay, the resulting truncated protein would be unlikely to retain significant function. INPPL1 encodes inositol polyphosphate phosphataselike 1 or SHIP2, a secondary messenger that has multiple roles in developmental processes including cellular proliferation, adhesion, and migration and metabolic functions such as glucose homeostasis and insulin signaling. [8] [9] [10] Because of the role of SHIP2 in energy metabolism, it has been intensely studied both in vitro and in animal models. In mice, absence of SHIP2 protein or decreased expression of a catalytically inactive SHIP2 results in multiple developmental defects including a shortened facial profile and diminished growth. 9, 10 Specifically, the Inppl1 À/À mice are about half the size of Inppl1 þ/þ mice, suggesting that the axial and appendicular skeleton must be affected. Inppl1 has been shown to be expressed at E14.5 in the developing axial and appendicular skeletal elements (Eurexpress), further supporting its role in skeletogenesis. The mechanism by which loss of SHIP2 affects skeletal development is unknown because, beyond its catalytic function, SHIP2 has been shown to act as a docking protein for many other cytoplasmic molecules. 11 In summary, we used linkage analysis and wholegenome sequencing of a consanguineous trio to discover that mutations in INPPL1 cause opsismodysplasia and explain~60% of cases in our cohort. The clinical characteristics of individuals with opsismodysplasia caused by INPPL1 mutations were indistinguishable from those without INPPL1 mutations and included both individuals with severe renal phosphate wasting and those in whom no such abnormality had been reported. This observation suggests that opsismodysplasia is genetically heterogeneous. Our findings further support a role for SHIP2 in the development of the craniofacial, axial, and appendicular skeleton. 10 
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